<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Primaquine</id>
	<title>Primaquine - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Primaquine"/>
	<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Primaquine&amp;action=history"/>
	<updated>2026-04-28T20:36:59Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://idwiki.org/index.php?title=Primaquine&amp;diff=10895&amp;oldid=prev</id>
		<title>Aidan at 15:54, 15 October 2024</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Primaquine&amp;diff=10895&amp;oldid=prev"/>
		<updated>2024-10-15T15:54:30Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 15:54, 15 October 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 6:&lt;/td&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 6:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Dosing ==&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Dosing ==&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-empty diff-side-deleted&quot;&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* &#039;&#039;&#039;Note:&#039;&#039;&#039; in Canada, the form is as a phosphate oral tablet, where 26.3 mg is equivalent to 15 mg primaquine base&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Malaria: 30 mg p.o. daily for 14 days, in conjunction with other appropriate antimalarial&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Malaria: 30 mg p.o. daily for 14 days, in conjunction with other appropriate antimalarial&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[Pneumocystis jirovecii]]: 30 mg p.o. once daily in combination with [[clindamycin]] for 21 days&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* [[Pneumocystis jirovecii]]: 30 mg p.o. once daily in combination with [[clindamycin]] for 21 days&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;

&lt;!-- diff cache key site7_mediawiki:diff:1.41:old-10894:rev-10895:wikidiff2=table:1.13.0:bc2a06be --&gt;
&lt;/table&gt;</summary>
		<author><name>Aidan</name></author>
	</entry>
	<entry>
		<id>https://idwiki.org/index.php?title=Primaquine&amp;diff=10894&amp;oldid=prev</id>
		<title>Aidan: Created page with &quot;== Background ==  * Antimalarial medication * Indications include malaria and Pneumocystis  == Dosing ==  * Malaria: 30 mg p.o. daily for 14 days, in conjunction with other appropriate antimalarial * Pneumocystis jirovecii: 30 mg p.o. once daily in combination with clindamycin for 21 days  === Renal Dosing ===  * No dose adjustments.  == Safety ==  * For G6PD deficiency, should be avoided or dose-reduced  Category:Antimicrobials Category:Antimal...&quot;</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Primaquine&amp;diff=10894&amp;oldid=prev"/>
		<updated>2024-10-15T15:53:32Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;== Background ==  * Antimalarial medication * Indications include &lt;a href=&quot;/Malaria&quot; class=&quot;mw-redirect&quot; title=&quot;Malaria&quot;&gt;malaria&lt;/a&gt; and &lt;a href=&quot;/Pneumocystis&quot; class=&quot;mw-redirect&quot; title=&quot;Pneumocystis&quot;&gt;&lt;i&gt;Pneumocystis&lt;/i&gt;&lt;/a&gt;  == Dosing ==  * Malaria: 30 mg p.o. daily for 14 days, in conjunction with other appropriate antimalarial * &lt;a href=&quot;/Pneumocystis_jirovecii&quot; title=&quot;Pneumocystis jirovecii&quot;&gt;&lt;i&gt;Pneumocystis jirovecii&lt;/i&gt;&lt;/a&gt;: 30 mg p.o. once daily in combination with &lt;a href=&quot;/Clindamycin&quot; title=&quot;Clindamycin&quot;&gt;clindamycin&lt;/a&gt; for 21 days  === Renal Dosing ===  * No dose adjustments.  == Safety ==  * For &lt;a href=&quot;/G6PD_deficiency&quot; title=&quot;G6PD deficiency&quot;&gt;G6PD deficiency&lt;/a&gt;, should be avoided or dose-reduced  &lt;a href=&quot;/Category:Antimicrobials&quot; title=&quot;Category:Antimicrobials&quot;&gt;Category:Antimicrobials&lt;/a&gt; Category:Antimal...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== Background ==&lt;br /&gt;
&lt;br /&gt;
* Antimalarial medication&lt;br /&gt;
* Indications include [[malaria]] and [[Pneumocystis]]&lt;br /&gt;
&lt;br /&gt;
== Dosing ==&lt;br /&gt;
&lt;br /&gt;
* Malaria: 30 mg p.o. daily for 14 days, in conjunction with other appropriate antimalarial&lt;br /&gt;
* [[Pneumocystis jirovecii]]: 30 mg p.o. once daily in combination with [[clindamycin]] for 21 days&lt;br /&gt;
&lt;br /&gt;
=== Renal Dosing ===&lt;br /&gt;
&lt;br /&gt;
* No dose adjustments.&lt;br /&gt;
&lt;br /&gt;
== Safety ==&lt;br /&gt;
&lt;br /&gt;
* For [[G6PD deficiency]], should be avoided or dose-reduced&lt;br /&gt;
&lt;br /&gt;
[[Category:Antimicrobials]]&lt;br /&gt;
[[Category:Antimalarials]]&lt;/div&gt;</summary>
		<author><name>Aidan</name></author>
	</entry>
</feed>